secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVAI BIO, INC. (AVAI)
CIK:        0001740797
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001740797-24-000015
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avant Technologies CEO & COO resign; William Hisey named Interim CEO
--------------------------------------------------------------------

- Timothy Lantz resigned as CEO and Director effective April 24, 2024, without conflicts with the Board.
- Angela Harris resigned as COO and Jared Pelski as VP Business Development, effective April 24, 2024.
- William Hisey appointed Interim CEO effective April 25, 2024; base salary $4,000/month plus quarterly RSA of 70,000 shares.
- All three prior employment agreements (Lantz, Pelski, Harris) canceled by mutual consent; no claims outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/0001740797-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740797/000174079724000015/avai8k_.htm
  HTML page:      https://secwatch.observer/filing/0001740797-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer